Skip to main content

Want a detailed portfolio tracker?

Amicus Therapeutics (FOLD) P/E (2011 - 2026)

Amicus Therapeutics (FOLD) P/E from Mar 31, 2011 to Apr 27, 2026. The TTM Amicus Therapeutics (FOLD) P/E is -164.36. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Amicus Therapeutics (FOLD)

YearP/EChange
2026-164.36+1.76%
2025-161.52+225.27%
2024-49.66+113.62%
2023-23.25+79.55%
2022-12.95+2.91%
2021-12.58-41.82%
2020-21.62+221.64%
2019-6.72+29.54%
2018-5.19-34.84%
2017-7.97+124.33%
2016-3.55-58.72%
2015-8.60-59.95%
2014-21.48+953.28%
2013-2.04-22.67%
2012-2.64-20.76%
2011-3.33N/A

Comparison Amicus Therapeutics (FOLD) P/E with competitors

Amicus Therapeutics (FOLD) P/E is -164.36.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.00%
ENLVEnlivex Ltd0.07-100.05%
FGENFibroGen Inc0.24-100.15%
CHRSCoherus Biosciences Inc0.85-100.52%
FBIOFortress Biotech Inc0.95-100.58%
ORMPOramed Pharmaceuticals Inc1.50-100.91%
AGENAgenus Inc3.01-101.83%
INVAInnoviva Inc3.15-101.92%
VXRTVaxart Inc3.55-102.16%
CRMDCorMedix Inc3.63-102.21%
CVACCureVac N.V.4.45-102.70%
GLPGGalapagos NV4.86-102.96%
SRPTSarepta Therapeutics Inc4.88-102.97%
ABEOAbeona Therapeutics Inc5.39-103.28%
ABUSArbutus Biopharma Corp5.60-103.40%
ZVRAZevra Therapeutics Inc5.89-103.58%
SPROSpero Therapeutics Inc6.23-103.79%
CGENCompugen Ltd6.31-103.84%
RIGLRigel Pharmaceuticals6.87-104.18%
SLXNSilexion Therapeutics Corp7.30-104.44%
OMEROmeros Corporation9.26-105.63%
AUPHAurinia Pharmaceuticals Inc9.58-105.83%
PLXProtalix BioTherapeutics Inc10.89-106.63%
ACADAcadia Pharmaceuticals Inc11.73-107.14%
TBPHTheravance Biopharma Inc12.26-107.46%
ADMAAdma Biologics Inc12.42-107.56%
HRMYHarmony Biosciences Holdings Inc13.82-108.41%
SABSSAB Biotherapeutics Inc14.14-108.60%
NAGENiagen Bioscience Inc14.82-109.02%
INCYIncyte Corp15.82-109.63%
REGNRegeneron Pharmaceuticals Inc15.86-109.65%
PBYIPuma Biotechnology Inc17.32-110.54%
CPRXCatalyst Pharmaceuticals Inc17.44-110.61%
EXELExelixis Inc17.54-110.67%
TGTXTG Therapeutics Inc18.97-111.54%
MDXGMimedx Group Inc20.55-112.50%
XOMAXOMA Royalty Corp22.87-113.92%
ARGXArgen X SE24.30-114.78%
CTMXCytomX Therapeutics Inc24.82-115.10%
XOMAOXOMA Royalty Corp25.34-115.42%
HALOHalozyme Therapeutics Inc25.62-115.59%
XOMAPXOMA Royalty Corp25.67-115.62%
VRTXVertex Pharmaceuticals Inc27.99-117.03%
RPRXRoyalty Pharma plc - Class A28.69-117.45%
SLNOSoleno Therapeutics Inc29.02-117.65%
ASNDAscendis Pharma A/S30.09-118.30%
LGNDLigand Pharmaceuticals Inc - Class B37.91-123.07%
APLSApellis Pharmaceuticals Inc39.02-123.74%
BMRNBiomarin Pharmaceutical Inc42.21-125.68%
KRYSKrystal Biotech Inc45.34-127.59%
ONCBeiGene Ltd69.54-142.31%
PHARPharming Group N.V.75.03-145.65%
TECHBio-Techne Corp101.96-162.03%
VCELVericel Corp109.92-166.88%
ALNYAlnylam Pharmaceuticals Inc117.96-171.77%
GMABGenmab140.29-185.36%
TLXTelix Pharmaceuticals Ltd162.15-198.66%
CORTCorcept Therapeutics Inc212.86-229.51%